No Detail Found!

Long-Term Effect of Post-Covid-19 Syndrome on Respiratory Parameters in Iraqi People

Author(s)
Sara Basim Zwain Medical Physiology, Department of Basic Sciences, College of Dentistry, University of Maysan, Iraq
Sami R. Alkatib Department of Medical Physiology, Faculty of Medicine, University of Kufa, Iraq
Falah Mahdi Danana Department of Medical Physiology, Faculty of Medicine, University of Kufa, Iraq
Basim MH Zwain Medical Physiology, Department of Basic Sciences, College of Dentistry, University of Al-Ameed, Iraq
Abstract
Background: The long-term sequelae of COVID-19 are thought to be a novel area of research due to variances in the epidemiology and therapy. Nevertheless, the follow-up time interval (6 or 12 months) was excessively long, and the time point of the follow-up period varied from 3 to 24 months in the prior research. More research is required to understand better COVID-19's effects, including their long-term effects on the lungs and how they may affect pulmonary function. Therefore, this study aims to investigate the long-term impact of post-COVID-19 syndrome on pulmonary function tests. Methods: This research was a case-control study conducted from 13 October 2023 to 13 November 2023 at the Al-Sader Teaching Hospital in Maysan City. There are fifty-eight patients and fifty-eight controls included. This study comprised patients who visited a pulmonary consulting clinic and had COVID-19 symptoms, matched by controls who were chosen at random. The controls had to meet the same criteria as the cases, with the exception that they did not have COVID-19 disease. The most popular kind of breathing or pulmonary function test is spirometry, spirometry was used to measure: FVC, FEV, and FEV1/FVC ratio. Result: sixty-six post covid19 syndrome with ages (34.1 ± 9.8) years and sixty-seven controls were enrolled. The results of FVC and FEV parameters indicate a significant difference (P<0.05) between cases and control groups. However, no significant differences existed between groups for the FEV1/FVC ratio. In the comparison of lung function tests between cases and control across different age groups (18-29, 30-39, 50-65) years, we found that mean FVC is significantly lower for the age group 18-29 years than for 30-39 and 50-65 years, and the mean FEV is significantly lower for the age group 18-29 years than for 30-39. Conclusion: After COVID-19, a significant number of patients continue to have symptoms, with respiratory symptoms accounting for the majority of complaints. Patients with continuing symptoms were younger and presented a significantly lower FVC and FEV.
Publication Details
Page(s) 175-181
Published Journal: Journal of Pioneering Medical Sciences, Volume: 13, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Spirometry, Pulmonary function test, Coronavirus disease 2019 (COVID-19), lung function test, Post Covid-19, long covid
References
Botek M.,Krejcˇí M.,Valenta M.,McKune A.,Sládecˇková B.,Konecˇný P.,Pastucha D. .1992 .Molecular hydrogen positively affects physical and respiratory function in acute post-COVID-19 patients: a new perspective in rehabilitation. International Journal of Environmental Research and Public Health, 19(4) : .
Davis H. E.,Assaf G. S.,McCorkell L.,Wei H.,Low R. J.,Akrami A. .2021 .Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine, 38 : .
Al-Kuraishy H. M.,Al-Maiahy T. J.,Al-Gareeb A. I.,Musa R. A.,Ali Z. H. .2020 .COVID-19 pneumonia in an Iraqi pregnant woman with preterm delivery. Asian Pacific Journal of Reproduction, 9(3) : 156-158.
Pierce J. D.,Shen Q.,Cintron S. A.,Hiebert J. B. .2022 .. PostCOVID-19 syndrome. Nursing Research, 71(2) : 164-174.
Fumagalli A.,Misuraca C.,Bianchi A.,Borsa N.,Limonta S.,Maggiolini S.,Colombo D. .2021 .Pulmonary function in patients surviving to COVID-19 pneumonia. , 49 : 153-157.
Mahmood Z. S.,Fadhil H. Y.,Ad A. H. .2021 .Estimation of hematological parameters of disease severity in Iraqi patients with COVID-19. Iraqi Journal of Science, 3487 : 3496.
Sirayder U.,Inal-Ince D.,Kepenek-Varol B.,Acik C. .2022 .Longterm characteristics of severe COVID-19: respiratory function, functional capacity, and quality of life. International Journal of Environmental Research and Public Health, 19(10) : 6304.
McGroder C. F.,Zhang D.,Choudhury M. A.,Salvatore M. M.,D'Souza B. M.,Hoffman E. A.,Garcia C. K. .2021 .Pulmonary ifbrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length. Thorax, 76(12) : 1242-1245.
Maher T. M.,Corte T. J.,Fischer A.,Kreuter M.,Lederer D. J.,Cottin M.,V. M. .2020 .Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet Respiratory Medicine, 8(2) : 147-157.
Lopez-Leon S.,Wegman-Ostrosky T.,Perelman C.,Sepulveda R.,Rebolledo P. A.,Cuapio A.,Villapol S. .2021 .More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific reports, 11(1) : 1-12.
Hassan S. M.,Obeid H. A.,Hasan I. S.,Abbas A. N. .2023 .Etanercept ameliorated cerebral damage during global cerebral ischemiareperfusion injury in male rats. Azerbaijan Pharmaceutical and Pharmacotherapy Journal, 22(1) : 53-58.
Sansores R. H.,Ramírez-Venegas A.,Montiel-Lopez F.,DomínguezArellano S.,Alva-Lopez L. F.,Falfán-Valencia R.,Cazzola M. .2023 .Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy. Respiratory Medicine, 217 : 107362.
Franco J. V. A.,Garegnani L. I.,Oltra G. V.,Metzendorf M. I.,Trivisonno L. F.,Sgarbossa N.,Scheidt-Nave C. .2022 .Longterm health symptoms and sequelae following SARS-CoV-2 infection: an evidence map. International Journal of Environmental Research and Public Health, 19(16) : 9915.
Krueger van Zeeland,Mehagnoul-Schipper R.,Barten D. J.,Osch D. G.,F. H. D. G. .2023 .Pulmonary function three to vfie months after hospital discharge for COVID-19: a single centre cohort study. Scientific Reports, 13(1) : 681.
Hassan S. M.,Mohammed M. H.,Jawad M. J.,Abbas A. N. .2023 .Use of Infliximab to Attenuate Cerebral Apoptosis Induced by Cerebral Ischemia/reperfusion in Male Rats. Polish Ministry of Education and Science, Polish Medical Bibliography, 76(2) : 326-331.
Liu J. .2023 .Vascular Dysfunctions Contribute to the Long-term Cognitive Deficits Following COVID-19.. , : .
Kusumawardani R. I.,Tinduh D.,Poerwandari D.,Marhana I. A.,Melaniani S. .2023 .The effectiveness of incentive spirometry exercise on pulmonary function in COVID-19 survivors: a randomized controlled trial study. Bali Medical Journal, 12(1) : 539-544.
Chaiwong W.,Deesomchok A.,Pothirat C.,Liwsrisakun C.,Duangjit P.,Bumroongkit C.,Niyatiwatchanchai N. .2023 .The long-term impact of COVID-19 pneumonia on pulmonary function and exercise capacity. Journal of Thoracic Disease, 15(9) : 4725-4735.
Salem A. M.,Khathlan Al,Alharbi N.,Alghamdi A. F.,AlDuilej T.,Alghamdi S.,Sabit M.,H. M. .2021 .The long-term impact of COVID-19 pneumonia on the pulmonary function of survivors. International Journal of General Medicine, : 3271-3280.
Huang L.,Yao Q.,Gu X.,Wang Q.,Ren L.,Wang Y.,Cao B. .2021 .1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. The Lancet, 398(10302) : 747-758.
Suppini N.,Fira-Mladinescu O.,Traila D.,Motofelea A. C.,Marc M. S.,Manolescu D.,Oancea C. .2023 .Longitudinal Analysis of Pulmonary Function Impairment One Year Post-COVID-19: A SingleCenter Study. Journal of Personalized Medicine, 13(8) : 1190.
Zhang H.,Li X.,Huang L.,Gu X.,Wang Y.,Liu M.,Cao B. .2022 .Lung-function trajectories in COVID-19 survivors after discharge: a two-year longitudinal cohort study. EClinicalMedicine, 54 : 101668.
Ngai J. C.,Ko F. W.,Ng S. S.,Tong K. W.,Hui M.,D. S. M. .2010 .The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology, 15(3) : 543-550.
Pan F.,Yang L.,Liang B.,Ye T.,Li L.,Li L.,Zheng C. .2022 .Chest CT patterns from diagnosis to 1 year of follow-up in patients with COVID-19. , 302(3) : 709-719.
Hassan S. M. .2015 .Effect of Depression on Gestational Diabetes. International Journal of Recent Advances in Multidisciplinary Research, 02(11) : 0898-0902.
Bursac D.,Petridis D.,Zaric B.,Kovacevic T.,Stojsic V.,Sarcev T.,Karapantzou C. . .(2021). Long Term Respiratory Follow-Up for COVID19 Patients a Multicenter Study. Current Health Sciences Journal, 47(4) : 507-515.
Björsell T.,Sundh J.,Lange A.,Ahlm C.,Forsell M. N.,Tevell S.,Cajander S. .2023 .Risk factors for impaired respiratory function post COVID-19: A prospective cohort study of nonhospitalized and hospitalized patients. Journal of Internal Medicine, 293(5) : 600-614.
Güder G.,Brenner S.,Angermann C. E.,Ertl G.,Held M.,Sachs A. P.,Rutten F. H. .2012 .GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respiratory Research, 13 : 1-9.
0

Citations

0

Downloads

138

Views